Provisional approval was given to Sinovac for 12 to 17 years old: Malaysia


On Friday, Malaysia’s health ministry announced that a Covid-19 vaccine produced by China’s Sinovac had received provisional approval for use on young people aged 12 to 17. (Oct 1).
Teenagers under 18 started getting Covid-19 shots last month after more than 80% of adults had been vaccinated in one of Southeast Asia’s quickest vaccine roll-outs, covering 62 per cent of a 32 million-strong population.
Malaysia’s medicines authority advised preference for Sinovac’s product among teens without comorbidities or allergy issues or otherwise judged inappropriate for the Pfizer-BioNTech vaccine, according to a statement from the health ministry.
Malaysia announced in July that once supplies of the Sinovac vaccine ran out, it would cease administering it since it had enough alternative vaccinations for the national campaign.
Malaysia, on the other hand, has continued to receive more supplies. According to the foreign ministry, China agreed to give a million doses of the Sinovac vaccine this week, after a contribution of 500,000 doses in July.


Please enter your comment!
Please enter your name here

Enable Google Transliteration.(To type in English, press Ctrl+g)